Derhaschnig U - Search Results

1

Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein phosphorylation to assess P2Y12 -inhibition after ticagrelor intake.

Hobl EL, Jilma B, Derhaschnig U, Schoergenhofer C, Schwameis M, Jilma-Stohlawetz P. Hobl EL, et al. Among authors: derhaschnig u. Cytometry B Clin Cytom. 2015 Nov-Dec;88(6):385-8. doi: 10.1002/cyto.b.21119. Epub 2013 Aug 26. Cytometry B Clin Cytom. 2015. PMID: 24038908 Free article.

2

Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room.

Derhaschnig U, Laggner AN, Röggla M, Hirschl MM, Kapiotis S, Marsik C, Jilma B. Derhaschnig U, et al. Clin Chem. 2002 Nov;48(11):1924-30. Clin Chem. 2002. PMID: 12406977 Clinical Trial.

3

Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia.

Jilma B, Joukhadar C, Derhaschnig U, Rassoul F, Richter V, Wolzt M, Dorner GT, Petternel V, Wagner OF. Jilma B, et al. Among authors: derhaschnig u. Clin Sci (Lond). 2003 Feb;104(2):189-93. doi: 10.1042/CS20020168. Clin Sci (Lond). 2003. PMID: 12546641 Clinical Trial.

4

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.

Derhaschnig U, Reiter R, Knöbl P, Baumgartner M, Keen P, Jilma B. Derhaschnig U, et al. Blood. 2003 Sep 15;102(6):2093-8. doi: 10.1182/blood-2003-02-0416. Epub 2003 May 15. Blood. 2003. PMID: 12750166 Free article. Clinical Trial.

5

Endotoxaemia modulates Toll-like receptors on leucocytes in humans.

Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B. Marsik C, et al. Among authors: derhaschnig u. Br J Haematol. 2003 May;121(4):653-6. doi: 10.1046/j.1365-2141.2003.04350.x. Br J Haematol. 2003. PMID: 12752109 Free article.

6

Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans.

Reiter R, Derhaschnig U, Spiel A, Keen P, Cardona F, Mayr F, Jilma B. Reiter R, et al. Among authors: derhaschnig u. Thromb Haemost. 2003 Nov;90(5):898-903. doi: 10.1160/TH03-04-0245. Thromb Haemost. 2003. PMID: 14597986

7

Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia.

Derhaschnig U, Pachinger C, Schweeger-Exeli I, Marsik C, Jilma B. Derhaschnig U, et al. Thromb Haemost. 2003 Dec;90(6):1054-60. doi: 10.1160/TH03-04-0233. Thromb Haemost. 2003. PMID: 14652636 Clinical Trial.

8

Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial.

Derhaschnig U, Pachinger C, Jilma B. Derhaschnig U, et al. Am Heart J. 2004 Apr;147(4):E17. doi: 10.1016/j.ahj.2003.11.003. Am Heart J. 2004. PMID: 15077100 Clinical Trial.

9

Mechanism of action of drotrecogin alfa activated (rhAPC).

Jilma B, Derhaschnig U. Jilma B, et al. Among authors: derhaschnig u. Thromb Haemost. 2004 May;91(5):1050. Thromb Haemost. 2004. PMID: 15116270 No abstract available.

10

Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.

Derhaschnig U, Bergmair D, Marsik C, Schlifke I, Wijdenes J, Jilma B. Derhaschnig U, et al. Crit Care Med. 2004 May;32(5):1136-40. doi: 10.1097/01.ccm.0000126265.08175.be. Crit Care Med. 2004. PMID: 15190963 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page